Clinical Trials Logo

Clinical Trial Details — Status: Suspended

Administrative data

NCT number NCT02433197
Other study ID # FCCSS-UMA_04-15
Secondary ID
Status Suspended
Phase N/A
First received
Last updated
Start date December 2015

Study information

Verified date March 2017
Source University of Malaga
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: Patients with testicular germ cell cancer (GCC) have a high cure rate, however impaired muscle function and fatigue are the most common complications among patients with GCC undergoing treatment with chemotherapy. Although exercise is widely recommended, information about physiopathological effects of cancer therapy in skeletal muscle is very limited. Methods/Design: The present study is a randomized controlled trial comparing an individualized program of muscular strength and endurance with aerobic training compared to a control group. All variables will be measured at the beginning and at the end of a 8-week intervention by the same evaluator, who will hide the disposition of participants to each group. Besides, it will be monitoring during de following 6 months (24 weeks) after training for all outcome variables.


Description:

Background: Patients with testicular germ cell cancer (GCC) have a high cure rate, however impaired muscle function and fatigue are the most common complications among patients with GCC undergoing treatment with chemotherapy. Although exercise is widely recommended, information about physiopathological effects of cancer therapy in skeletal muscle is very limited. Our aim is to evaluate the effects of an individualized exercise program with aerobic training in water running on cancer-related fatigue. Methods/Design: The present study is a randomized controlled trial comparing an individualized program of muscular strength and endurance with aerobic training compared to a control group. The investigators will conduct this trial in patients undergoing chemotherapy, recruited by the Departament of Oncology of Virgen de la Victoria Hospital (Málaga). Patients will be included and evaluated before the first cycle of chemotherapy and assigned experimental or control group randomly. All variables will be measured at the beginning and at the end of a 8-week intervention by the same evaluator, who will hide the disposition of participants to each group. Besides, it will be monitoring during de following 6 months (24 weeks) after training for all outcome variables.


Recruitment information / eligibility

Status Suspended
Enrollment 20
Est. completion date
Est. primary completion date April 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Patients programmed to chemotherapy Exclusion Criteria: -

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Aerobic program
The intervention will be an 8-week program of individualized physiotherapy strength and muscular endurance with aerobic training, led by physiotherapists in groups of 8-10 participants. Each program will be individualized based on the evaluations of muscular strength and enduranceas well as determination of aerobic-anaerobic zone transition described in previous studies In sessions of one hour 3 times a week. Each session will consist of 30 minutes of exercises performed on land followed by 20 minutes of continuous running in treadmill. In week 1 and 2 participants carry out 3 sets of 15 repetitions (reps) to become familiar with the exercises. From week 3 onwards participants will perform 4 sets of 10 reps. If the participant can do more than 12 reps, weight will be increased. All exercises are conducted supervised to ensure proper technique and adequate progression.

Locations

Country Name City State
Spain Antonio Cuesta-Vargas Malaga

Sponsors (1)

Lead Sponsor Collaborator
University of Malaga

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Cancer-related fatigue QuickPiper scale The primary outcome will be fatigue, assessed by the revised Cancer-related fatigue QuickPiper scale, with the semi-structured interview used by Cella et al (1998) to define phenotype of CRF 20 minutes
Secondary Sf-12 The state of physical and mental health 10 min
Secondary EuroQoL-5D Quality of life 10 min
Secondary Profile of Mood States It is possible to obtain an overall index of altered mood and seven partial measures: stress / anxiety, depression / rejection, anger / hostility, vigor / activity, fatigue / inertia and confusion / bewilderment 10 min
Secondary Physical condition test strength peak of knee extension (quadriceps), knee flexion (hamstring), elbow extension (brachial triceps) and elbow flexion (biceps brachii) by one dynamometry instrumented with Powertruck II of JTECH, following the protocol described by Daniels & Worthingham (1995). Hand grip strength will be evaluated by the hydraulic dynamometer JAMAR 20 min
Secondary C-reactive protein (CRP) It will be measured in blood samples following clinical standards in 10 ml venous blood 20 min
Secondary Tumor Necrosis Factor alpha (TNF-a) It will be measured in blood samples following clinical standards in 10 ml venous blood sample. 20 min
Secondary Interleukin-6 (IL-6), Interleukin-18 (IL-18), Interleukin-4 (IL-4) and Interleukin-10 (IL 10) It will be measured in blood samples following clinical standards in 10 ml venous blood 20 min
Secondary high density lipoprotein (HDL), low density lipoprotein (LDL) cholesterol, triglycerides It will be measured in blood samples following clinical standards in 10 ml venous blood 20 min
See also
  Status Clinical Trial Phase
Recruiting NCT04914026 - MicroRNA as Markers in Testicular Cancer